Philippine regulator approves emergency use of AstraZeneca vaccine
MANILA (Reuters) - The Philippines' Food and Drug Administration (FDA) has approved the emergency use of AstraZeneca PLC's COVID-19 vaccine, the second to be approved in the Southeast Asian nation.
The known and potential benefits of AstraZeneca's COVID-19 vaccine outweighed the risks to date, FDA chief Rolando Enrique Domingo told a news conference. The Philippines' FDA has previously approved Pfizer and BioNTech's coronavirus vaccine.
(Reporting by Neil Jerome Morales; Editing by Ed Davies)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.